2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theLiver Disease Diagnostics Market?

The liver disease diagnostics market is predicted to grow due to the escalating alcohol consumption habits. Factors contributing to the increased alcohol consumption include changes in societal norms, enhanced economic capabilities, increased accessibility, and heightened stress or mental health issues. Performing diagnostics for liver disease is vital in assessing the effect of alcohol on the liver, and it assists in identifying early symptoms of liver damage such as fatty liver, hepatitis, or cirrhosis. For example, the National Health Service, a government body in England, reported in December 2022 that the percentage of people who drank alcohol in the preceding 12 months increased with age; starting at 62% among the 16 to 24 age group and peaking at 85% among those aged 55 to 74. Hence, the rise in alcohol consumption is a significant factor in the expansion of the liver disease diagnostics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

#What Long-Term Growth Rate is Expected for theLiver Disease Diagnostics Market Between 2025 and 2034?

The market for the diagnosis of liver disease has expanded significantly in the past few years. From being worth $36.26 billion in 2024, it is projected to increase to $39.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The historical growth of this market can be credited to a rise in acute and chronic liver disorders, heightened incidences of liver diseases, an upsurge in alcohol consumption, a growing consciousness about liver health, and a burgeoning healthcare infrastructure.

The market size for liver disease diagnostics is projected to experience substantial growth in the upcoming years, reaching an estimated $52.04 billion by 2029 with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the forecast period include a burgeoning elderly populace, increased investment in research & development, the escalating number of biopsy processes and diseases, and a broader acceptance of telemedicine. Noteworthy trends for this period are the emergence of individualized medicine, advances in diagnostic kit technology, progress in rapid tests, improvements in healthcare sector technology, and innovation in diagnostic methods.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

What Are the Current Market Growth and Trends in theLiver Disease Diagnostics Market That Industry Players Should Watch?

Leading organizations in the field of liver disease diagnostics are lending their focus towards the invention of advanced solutions like non-invasive tools for evaluating the liver, in an effort to create more precise and efficient diagnostic techniques. Non-invasive liver evaluation tools refer to assessment methods that scrutinize liver conditions using modalities such as elastography or blood examination, eliminating the necessity for invasive techniques like biopsies. An example of this advancement happened in September 2024, when an Indian diagnostic center named City Imaging & Clinical launched a non-invasive liver diagnostic tool called FibroScan. This tool’s main aim is to detect liver conditions, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), at an early stage. This state-of-the-art technology enables fast and precise evaluation of liver stiffness and fat content, eliminating the need for invasive techniques like biopsies. The procedure is swift, typically ranging from 5 to 15 minutes, and involves placing a probe on the skin above the liver. The probe sends out sound waves to measure the stiffness of the liver tissue, which aids in evaluating fibrosis or scarring.

What Are the Major Market Players Making an Impact on theLiver Disease Diagnostics Market Growth?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

How Are the Key Segments of the Liver Disease Diagnostics Market Driving Opportunities and Innovations?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theLiver Disease Diagnostics Market?# Market Expansion?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2025, By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: